This course focuses on understanding the pathophysiology of obesity, understanding obesity stigma and improving patient conversations, incorporating motivational interviewing techniques, the utility of different dietary interventions in weight management and the role of behavior in dietary modification, the challenges of initiating and maintaining physical activity, polypharmacy in weight management, and surgical and endoscopic approaches to weight loss. It is targeted to deliver comprehensive education on practical aspects of patient care through interactive and multi-faceted learning opportunities. This course series features 6 programs providing free continuing medication education credit. You can take courses individually or the entire package dependent on your learning needs. 

As leaders in endocrinology and obesity medicine, Endocrine Society and The Obesity Society are collaborating to address knowledge, skill, and workforce gaps surrounding obesity care and management. By offering an interactive and multi-faceted learning opportunity, this program delivers comprehensive education on practical aspects of patient care.  We thank Novo Nordisk for generously supporting this program.

Each module will include:

• Recorded presentations
• Knowledge, skill, or perception questions
• Clinical case vignettes
• Answer comparisons
• Additional Practice Resources

Modules

1. Understanding the Pathophysiology of Obesity & the Weight Reduced State
2. Shepherding the Difficult Conversation & Assessing the Patient with Obesity
3. Lifestyle Prescription: Behavior and Nutrition
4. Lifestyle Prescription: Behavior and Physical Activity
5. Updates in the Landscape and Application of Pharmacotherapy
6. Surgical and Endoscopic Approaches to Weight Loss

Upon completion of this course learners will be able to:

1. Review and identify the available and emerging therapeutic approaches to obesity.
2. Gain working knowledge of new medications in the pipeline to treat and manage obesity. 
3. Review different approaches to weight loss/maintenance and discuss methods necessary to improve patient treatment adherence.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 6.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Faculty by Module:

1. Daniel Bessesen, MD: Understanding the Pathophysiology of Obesity & the Weight Reduced State
2. Scott Kahan, MD, MPH: Shepherding the Difficult Conversation & Assessing the Patient with Obesity
3. amy D. Ard, MD: Lifestyle Prescription: Behavior and Nutrition
4. John M. Jakicic, PhD: Lifestyle Prescription: Behavior and Physical Activity
5. Marc-Andre Cornier, MD: Updates in the Landscape and Application of Pharmacotherapy
6. Sangeeta Kashyap, MD: Surgical and Endoscopic Approaches to Weight Loss

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the ACCME, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's EBR faculty. There are no commercial supporters of this activity, and no commercial entities have had influence over the planning of this CME activity.  

The following faculty reported no relevant financial relationships: Daniel Bessesen, MD, Scott Kahan, MD, MPH, Sangeeta Kashyap, MD

The following faculty reported  relevant financial relationships during the content development process for this activity:  

• Jamy D. Ard, MD, Consultant, Nestle Healthcare Nutrition
• John M. Jakicic, PhD, Advisory Board, WW International, Inc.
• Marc-Andre Cornier, MD, Research Investigator, Rhythm Pharmaceutical

The following SPC Committee members reported financial relationships:

• Andjela T. Drincic, MD: Advisory Board Member, Corcept
• Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
• Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences, ATA Board Member
• Amy Rothberg, MD: Spouse, consultant of Merck
• Katherine Araque, MD: Speaker, Novo Nordisk; Advisory Board, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:

Beret Ann Casey, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by an independent medical educational grant from Novo Nordisk, Inc.